Related Experiment Video
Updated: Jun 28, 2025

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
Published on: July 7, 2023
Identification of cuproptosis-realated key genes and pathways in Parkinson's disease via bioinformatics analysis
Jia Song1, Jia Li1, Xiaochen Pei1
1Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China.
Introduction:
Parkinson's disease (PD) is the second most common worldwide age-related neurodegenerative disorder without effective treatments. Cuproptosis is a newly proposed conception of cell death extensively studied in oncological diseases. Currently, whether cuproptosis contributes to PD remains largely unclear.
Methods:
The dataset GSE22491 was studied as the training dataset, and GSE100054 was the validation dataset. According to the expression levels of cuproptosis-related genes (CRGs) and differentially expressed genes (DEGs) between PD patients and normal samples, we obtained the differentially expressed CRGs. The protein-protein interaction (PPI) network was achieved through the Search Tool for the Retrieval of Interacting Genes. Meanwhile, the disease-associated module genes were screened from the weighted gene co-expression network analysis (WGCNA). Afterward, the intersection genes of WGCNA and PPI were obtained and enriched using the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). Subsequently, the key genes were identified from the datasets. The receiver operating characteristic curves were plotted and a PPI network was constructed, and the PD-related miRNAs and key genes-related miRNAs were intersected and enriched. Finally, the 2 hub genes were verified via qRT-PCR in the cell model of the PD and the control group.
Results:
525 DEGs in the dataset GSE22491 were identified, including 128 upregulated genes and 397 downregulated genes. Based on the PPI network, 41 genes were obtained. Additionally, the dataset was integrated into 34 modules by WGCNA. 36 intersection genes found from WGCNA and PPI were significantly abundant in 7 pathways. The expression levels of the genes were validated, and 2 key genes were obtained, namely peptidase inhibitor 3 (PI3) and neuroserpin family I member 1 (SERPINI1). PD-related miRNAs and key genes-related miRNAs were intersected into 29 miRNAs including hsa-miR-30c-2-3p. At last, the qRT-PCR results of 2 hub genes showed that the expressions of mRNA were up-regulated in PD.
Conclusion:
Taken together, this study demonstrates the coordination of cuproptosis in PD. The key genes and miRNAs offer novel perspectives in the pathogenesis and molecular targeting treatment for PD.
Insights
This study reveals cuproptosis plays a role in Parkinson's disease (PD) pathogenesis. Key genes PI3 and SERPINI1 were identified as potential therapeutic targets for PD.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Parkinson's disease (PD) is a prevalent neurodegenerative disorder with no effective treatments.
- Cuproptosis, a form of cell death, is well-studied in cancer but its role in PD is unclear.
Purpose of the Study:
- To investigate the involvement of cuproptosis in Parkinson's disease.
- To identify key genes and microRNAs (miRNAs) associated with cuproptosis in PD.
Main Methods:
- Analysis of gene expression datasets (GSE22491, GSE100054) to identify differentially expressed cuproptosis-related genes (CRGs).
- Construction of protein-protein interaction (PPI) and weighted gene co-expression network analysis (WGCNA) networks.
- Identification and validation of key genes (PI3, SERPINI1) and associated miRNAs using qRT-PCR.
Main Results:
- Identified 525 differentially expressed genes (DEGs) in PD samples.
- Discovered 2 key genes, peptidase inhibitor 3 (PI3) and neuroserpin family I member 1 (SERPINI1), significantly associated with PD.
- Found 29 relevant miRNAs, including hsa-miR-30c-2-3p, and confirmed upregulated mRNA expression of PI3 and SERPINI1 in PD.
Conclusions:
- Cuproptosis is implicated in the pathogenesis of Parkinson's disease.
- Identified key genes and miRNAs provide novel insights for molecular targeting treatments for PD.
More Related Videos
Related Concept Videos
Parkinson's Disease: Overview
Neural Regulation
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

